ReWalk Personal Device Postmarket Study
Study Details
Study Description
Brief Summary
This study seeks to further evaluate the Multi-Tiered Training Program and to further explore the overall safety profile of the ReWalk Personal Device outside of the institutional setting under conditions of routine medical practice.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
This study will monitor and further describe the long-term safety of the ReWalk Personal Device for Subjects and their Companions in institutional and non-institutional environments, such as the clinic, home, and community. The study will also evaluate the adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Subjects, their Companions, and their Clinical Trainers, monitor and further describe all ReWalk Personal Device malfunctions and screen for potential Unexpected Adverse Events.
Study Design
Outcome Measures
Primary Outcome Measures
- Long-term safety of the ReWalk Personal Device for Subjects in institutional and non- institutional environments, as measured by 12-month incidence of all Serious Adverse Events in Subjects [12 Months]
- Long-term safety of the ReWalk Personal Device for Subjects in institutional and non- institutional environments, as measured by 12-month incidence of falls and fall- associated injuries [12 Months]
- Long-term safety of the ReWalk Personal Device for Companions in institutional and non-institutional environments, as measured by 12-month incidence of all Serious Adverse Events in Companions [12 Months]
- Adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Subjects, as measured by the proportion of Subjects enrolled in training who successfully complete the intended training [12 Months]
- Adequacy of the ReWalk Training Program for Subjects, measured by the proportion of Subjects who successfully completed the intended training who are able to demonstrate proficiencies at 12 months after completion of the intended training [12 Months]
- Adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Subjects, as measured by the Subjects' abilities to navigate surfaces and environments outside of the institutional environment in accordance with their training [12 Months]
- Adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Companions, as measured by the proportion of Companions enrolled in training who successfully complete the intended training [12 Months]
Secondary Outcome Measures
- Reliability of the ReWalk Personal Device, as measured by the rates of all device malfunctions [12 Months]
- Adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Subjects, as measured by the qualitative Prescribing Physician, Clinical Trainer, Companion, and Subject responses to directed and open-ended questioning [12 Months]
- Adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Companions, as measured by the qualitative Prescribing Physician, Clinical Trainer, Companion, and Subject responses to directed and open-ended questioning [12 Months]
- Adequacy of the Multi-Tiered Training Program of the ReWalk Personal Device for Clinical Trainers, as measured by the qualitative Clinical Trainer responses to directed and open-ended questioning [12 Months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
For use in institutional and non-institutional environments: Subjects with spinal cord injury at levels T7 to L5.
-
Age ≥ 18 years old;
-
Hands and shoulders can support crutches or a walker;
-
Healthy bone density;
-
Skeleton does not suffer from any fractures;
-
Able to stand using a device such as EasyStand;
-
In general good health;
-
Height is between 160 cm and 190 cm (5'3" - 6'2");
-
Weight does not exceed 100 kg (220 lbs);
-
Proficiency in spoken and written English language.
Exclusion Criteria:
-
History of severe neurological injuries or disease other than SCI (MS, CP, ALS, TBI, etc.);
-
Severe concurrent medical disease, including infections, circulatory, heart or lung, pressure sores;
-
Severe spasticity (Ashworth 4)
-
Uncontrolled clonus;
-
Unstable spine or unhealed limbs or pelvic fractures;
-
Heterotopic ossification;
-
Significant contractures;
-
Psychiatric or cognitive situations that may interfere with proper operation of the device or participation in this study;
-
Pregnancy
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Stanford University | Palo Alto | California | United States | 94304 |
| 2 | Casa Colina Hospital | Pomona | California | United States | 91767 |
| 3 | Rehabilitation Hospital of Indiana | Indianapolis | Indiana | United States | 46254 |
Sponsors and Collaborators
- ReWalk Robotics, Inc.
Investigators
- Principal Investigator: Mathew Smuck, MD, Stanford University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- RW-401